PATENT CLAIM ANALYSIS

Application Number: 16120946
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["435", "007100"]

Abstract:
Antibodies against citrullinated protein antigens (ACPA) have shown their relevance for the diagnosis and possibly pathogenesis in arthritis. Described are means and methods for determining antibodies against homocitrulline-containing proteins or carbamylated proteins/peptides (anti-CarP) for the classification of individuals suffering from, or at risk of suffering from, arthritis.

Claim (Index 3):
The method according to  claim 2 , wherein the body fluid is a serum sample or a synovial fluid sample.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 97.0
- Lexical Diversity: 1.34146
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15478461', '13983374', '15791354', '14806515', '13510091']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6966781235933798
- 35 USC 102 Novelty (BERT): 0.7338542462167557
- Combined Prediction Score: 0.7003957358557173
- Mean Citation Score: 620.167762
- Max Citation Score: 879.2645
- Similarity Product: 794.0086485477685

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test